Necrosis used to kill cancer

DNA alkylation destroys tumor cells in mice deficient in p53 and BCL-2

Written byJohn Dudley Miller
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A University of Pennsylvania research team has shown that it can kill tumor cells in mice by necrosis, rather than by inducing apoptosis, by giving them alkylating agents that block their energy supply. The authors of the study, which appears in the advanced online edition of Genes and Development, say the finding may give researchers another important mechanism with which to destroy cancer cells.

Craig Thompson and colleagues at the university's Abramson Family Cancer Research Institute bred mice to be deficient in two genes that help regulate death by apoptosis, p53, and BCL-2. In a series of experiments, the team proved that alkylating agents caused necrotic death in the tumor cells, according to the report.

The group also showed that providing another source of energy to both apoptotic-deficient tumor cells and tumors from wildtype apoptotic-competent mice prevented both groups of cells from dying, according to the article.

Although other researchers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies